Patent details

Basic Information

Publication number:

EP1341542

PCT Application Number:

PCT/EP/2001/014122

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP019993666

PCT Publication Number:

WO/2002/045703

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Indanylderivatives for treating airway diseases

French Title of Invention:

Dérivés indanyl pour le traitement de maladies des voies respiratoires

German Title of Invention:

Indanylderivate zur Behandlung von Atemwegserkrankungen

SPC Number:

Dates

Filing date:

03/12/2001

Grant date:

02/05/2007

EP Publication Date:

02/05/2007

PCT Publication Date:

13/06/2002

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

10/09/2003

EP B1 Publication Date:

02/05/2007

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

03/12/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

03/12/2001

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Name:

Novartis Pharma GmbH

Address:

Brunner Strasse 59, 1230 Wien, Austria (AT)

Inventor

1

Name:

CUENOUD Bernard,

Address:

Switzerland (CH)

2

Name:

FAIRHURST Robin Alec, Novartis Horsham Res Centre

Address:

United Kingdom (GB)

3

Name:

LOWTHER Nicholas, c/o Novartis Horsham Res Centre

Address:

United Kingdom (GB)

Priority

Priority Number:

0029562

Priority Date:

04/12/2000

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

A61K 31/575;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

24/11/2020

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages